2017-09-11 19:47:15 UTC

Share Your Cutting-Edge IBD Research

Sept. 11, 2017

The processing fee for oral and/or poster presentation is being waived. Submissions are due by October 31 at 9 p.m. ET.

Join the Crohn's & Colitis Foundation and the American Gastroenterological Association (AGA) for the inaugural Crohn's & Colitis Congress™, the must-attend meeting for all inflammatory bowel disease (IBD) professionals, taking place January 18-20, 2018 in Las Vegas.

  • Build a powerful network and share solutions with thought-leaders in IBD.
  • Learn together as one multi-disciplinary care team.
  • Determine best practices at every stage of the patient’s disease journey.
  • Discover cutting-edge basic, translational and clinical research in the IBD space.
  • Improve skills and patient outcomes.
  • Explore new technologies and products from IBD-related exhibitors.
  • Earn CME credits and MOC points.

Share your cutting-edge basic, translational and clinical research discoveries in IBD with the top leaders in the field. Submit for oral and/or poster presentation for free. The processing fee for the inaugural year of the Crohn’s & Colitis Congress is being waved. All accepted abstracts will be co-published in Gastroenterology and Inflammatory Bowel Diseases.

Abstract submissions end October 31 at 9 p.m. ET. Notifications will be sent December 4. Late-breaking abstracts will be accepted from November 28-December 8.

Travel Grants Available
Fellows, nurses, and advanced practice providers are encouraged to submit abstracts for oral presentation and be considered for a travel grant. Visit www.crohnscolitiscongress.org/abstracts.

 

More on Crohn's Disease

Tell Congress: Protect the Care of and Research for Digestive Disease Patients

Jan. 23, 2018

Join AGA Virtual Advocacy Day — Thursday, Jan. 25.

New Drugs for Inflammatory Bowel Disease (IBD)

Jan. 19, 2018

Breakthrough IBD research to be presented at the Crohn’s & Colitis Congress™

Beyond Drugs for IBD: Improving the Overall Health of IBD Patients

Jan. 19, 2018

Actionable IBD research to be presented at the Crohn’s & Colitis Congress™